Montpellier University Hospital
Montpellier, 34000, France
Location status: Recruiting
NCT Number: NCT06484387
The aim of this study is to precisely identify deficits in intra- and interpersonal multimodal synchronizations during social interaction in individuals with schizophrenia (ISZ). During a social interaction, individuals use both visual and auditory channels to construct their discourse. The auditory channel encompasses the semantics and prosody of the speech, while the visual channel describes the entirety of non-verbal gestures (e.g., facial expressions, body movements). Prosody and non-verbal gestures are essential elements for the speaker. By accompanying speech, they contribute to the planning and conceptualization of the utterance and enhance its communicative power. For the listener, prosody and non-verbal gestures are also used to provide sensory feedback to the speaker.
Several studies have shown the existence of intrapersonal and interpersonal synchronizations of prosody and non-verbal gestures during interaction. These synchronizations are associated with numerous social benefits (e.g., increased mutual appreciation and quality of interaction). However, certain mental disorders, such as schizophrenia, exhibit deficits in non-verbal behaviors that can impair these synchronizations and the associated social benefits. We hypothetized that interaction with individuals with a daignosis of schizophrenia will be associated with deficits in intra and interpersonal synchronization.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Montpellier, 34000, France
Location status: Recruiting
This study includes a pre-inclusion interview followed by a visit to the university hospital (CHU) lasting about 2 hours (including a break). During the visit, the patient participates in an experimental protocol consisting of two parts. In the first part, the patient will be paired with an interaction partner, and the two participants will engage in four distinct conversational tasks, including getting to know each other, free discussions, structured dialogues, and emotional interactions. In the second part, the participants will answer several questionnaires and perform neuropsychological tests in collaboration with an experimenter
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Individuals with a diagnosis of schizophrenia :
Inclusion criteria
Exclusion criteria
Healthy controls :
Inclusion criteria
Exclusion criteria
Participants are required to speak to one another. Participants are given various topics of conversation.
Time frame: 4x6 minutes
synchronization between body movements of two interacting partners
Time frame: 4x6 minutes
synchronization between voice and body movements of one individual
Time frame: 4x6 minutes
Time frame: 4x6 minutes
Contact information is provided by the study sponsor or research team.
Delphine Capdevielle, Pr
CONTACT
Mathilde Parisi
CONTACT
University Hospital, Montpellier
Other
Study of Multimodal Intra- and Interpersonal Synchronizations in Social Interaction in Individuals with a Diagnosis of Schizophrenia.
Acronym: ENHANCER1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07045142
Dyslipidemias, Lipid Metabolism Disorders
Zhumadian, Henan, China
View Trial DetailsNCT07369154
Mental Disorders, Schizophrenia
Chandler, Arizona, United States
View Trial DetailsNCT07411222
Behavior, Bipolar Disorder
Bolu, Turkey (Türkiye)
View Trial DetailsNCT06882785
Mental Disorders, Schizophrenia
Kōnan, Aichi-ken, Japan
View Trial Details